about
Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newbornPathophysiology and treatment of septic shock in neonates.Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn.Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signalingHyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cellsAntidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newbornNitric oxide and beyond: new insights and therapies for pulmonary hypertension.Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.Current and future therapeutic options for persistent pulmonary hypertension in the newborn.Vascular abnormalities in human newborns with pulmonary hypertension.Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.Role of reactive oxygen species in neonatal pulmonary vascular disease.Treating pulmonary hypertension in pediatrics.Lung Rest During Extracorporeal Membrane Oxygenation for Neonatal Respiratory Failure-Practice Variations and Outcomes.Cytoskeletal remodeling and regulation of cell fate in the hypertensive neonatal pulmonary artery in response to stress.Evaluation and management of the cyanotic neonateRegulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep.Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
P2860
Q27026121-73E9E536-5287-4731-A46D-25A34E9AF7C8Q33940492-CA3981C0-F050-42A5-B73A-EB8C9568B3C9Q34248154-D32A46C0-1B82-4ED3-AB3C-1386519433BCQ36330558-9051D427-0997-4D90-A637-7BFA94C1280DQ36498599-73B68133-A490-499E-B0B4-7C2CCEF135A2Q36600814-98B4AA40-30C6-40F8-BFDC-DF9498DFC5FCQ37341675-BC94F206-F242-4DAC-95A7-36A12F065908Q37510031-D657C745-1584-430A-A1B0-CDD0216D2E79Q37763202-95221F1A-6F5F-4B90-BD4A-48506682AC3BQ37867675-E077A281-AF06-479E-B18C-8E2901A2FF70Q37893072-190D9E55-A659-46EC-8321-9BCC27B600AFQ38040821-95BF3800-8DA8-47C0-B2AB-BF59762E6904Q38172267-C91D94BA-F08A-43BC-8D6C-AEB5D1084CB1Q38349395-B926C23C-20F6-4A53-B08E-1CF2C9317640Q38785958-167CED1A-38D2-4DE8-AA5B-B8FE89475E94Q39240587-140FA2BD-A2B0-4A7B-AC27-C6D1ADD85585Q41095711-06FF7FAF-BAA3-4719-8389-1B24B2058AFCQ42949886-0DE37514-3F2F-4E82-B3B2-EF33935CFC4BQ45987866-A930F90D-7AB6-45F4-AA60-F4CE638CCD0C
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The diseases treated with ECMO: focus on PPHN.
@ast
The diseases treated with ECMO: focus on PPHN.
@en
type
label
The diseases treated with ECMO: focus on PPHN.
@ast
The diseases treated with ECMO: focus on PPHN.
@en
prefLabel
The diseases treated with ECMO: focus on PPHN.
@ast
The diseases treated with ECMO: focus on PPHN.
@en
P2093
P1476
The diseases treated with ECMO: focus on PPHN.
@en
P2093
Kathryn N Farrow
Paola Fliman
Robin H Steinhorn
P356
10.1053/J.SEMPERI.2005.02.003
P577
2005-02-01T00:00:00Z